These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
548 related articles for article (PubMed ID: 25605937)
1. Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone. Tu X; Delgado-Calle J; Condon KW; Maycas M; Zhang H; Carlesso N; Taketo MM; Burr DB; Plotkin LI; Bellido T Proc Natl Acad Sci U S A; 2015 Feb; 112(5):E478-86. PubMed ID: 25605937 [TBL] [Abstract][Full Text] [Related]
2. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes. Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454 [TBL] [Abstract][Full Text] [Related]
3. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086 [TBL] [Abstract][Full Text] [Related]
4. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis. Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919 [TBL] [Abstract][Full Text] [Related]
5. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling. Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588 [TBL] [Abstract][Full Text] [Related]
6. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling. Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374 [TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength. Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532 [TBL] [Abstract][Full Text] [Related]
8. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance. Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359 [TBL] [Abstract][Full Text] [Related]
9. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Sapir-Koren R; Livshits G Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653 [TBL] [Abstract][Full Text] [Related]
10. Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain. Kedlaya R; Kang KS; Hong JM; Bettagere V; Lim KE; Horan D; Divieti-Pajevic P; Robling AG Endocrinology; 2016 Aug; 157(8):3047-57. PubMed ID: 27253995 [TBL] [Abstract][Full Text] [Related]
11. Postnatal β-catenin deletion from Dmp1-expressing osteocytes/osteoblasts reduces structural adaptation to loading, but not periosteal load-induced bone formation. Kang KS; Hong JM; Robling AG Bone; 2016 Jul; 88():138-145. PubMed ID: 27143110 [TBL] [Abstract][Full Text] [Related]
12. Adverse Effects of Osteocytic Constitutive Activation of ß-Catenin on Bone Strength and Bone Growth. Chen S; Feng J; Bao Q; Li A; Zhang B; Shen Y; Zhao Y; Guo Q; Jing J; Lin S; Zong Z J Bone Miner Res; 2015 Jul; 30(7):1184-94. PubMed ID: 25639729 [TBL] [Abstract][Full Text] [Related]
13. Insights into the antiosteoporotic mechanism of the soy-derived isoflavone genistein: Modulation of the Wnt/beta-catenin signaling. Mannino F; Imbesi C; Irrera N; Pallio G; Squadrito F; Bitto A Biofactors; 2024; 50(2):347-359. PubMed ID: 37767998 [TBL] [Abstract][Full Text] [Related]
14. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/β-catenin signaling in mice. Li J; Bao Q; Chen S; Liu H; Feng J; Qin H; Li A; Liu D; Shen Y; Zhao Y; Zong Z J Orthop Res; 2017 Apr; 35(4):812-819. PubMed ID: 27306622 [TBL] [Abstract][Full Text] [Related]
15. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. Canalis E; Adams DJ; Boskey A; Parker K; Kranz L; Zanotti S J Biol Chem; 2013 Aug; 288(35):25614-25625. PubMed ID: 23884415 [TBL] [Abstract][Full Text] [Related]
16. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor. Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638 [TBL] [Abstract][Full Text] [Related]
17. Bone-derived sclerostin and Wnt/β-catenin signaling regulate PDGFRα Kim SP; Da H; Wang L; Taketo MM; Wan M; Riddle RC FASEB J; 2021 Nov; 35(11):e21957. PubMed ID: 34606641 [TBL] [Abstract][Full Text] [Related]
18. Bone. Osteocyte-specific activation of the canonical Wnt-β catenin pathway stimulates bone formation. Osório J Nat Rev Endocrinol; 2015 Apr; 11(4):192. PubMed ID: 25645703 [No Abstract] [Full Text] [Related]
19. Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone. Ryan ZC; Craig TA; Salisbury JL; Carpio LR; McGee-Lawrence M; Westendorf JJ; Kumar R Biochem Biophys Res Commun; 2014 May; 448(1):83-8. PubMed ID: 24780398 [TBL] [Abstract][Full Text] [Related]
20. TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. Hens JR; Wilson KM; Dann P; Chen X; Horowitz MC; Wysolmerski JJ J Bone Miner Res; 2005 Jul; 20(7):1103-13. PubMed ID: 15940363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]